ATI RN
Immune System Medication Questions
Question 1 of 5
The nurse is caring for a patient who has a diagnosis of chronic hepatitis B infection and has been prescribed an immune stimulant. After teaching the patient about the treatment plan, how might the nurse evaluate the effectiveness of teaching?
Correct Answer: D
Rationale: The correct answer is D because the patient being able to state specific measures to avoid adverse effects demonstrates a comprehensive understanding of the treatment plan. This indicates that the patient not only understands the benefits of the medication but also the potential risks associated with it. This knowledge is crucial in ensuring the patient's safety and well-being throughout the treatment. A, B, and C are incorrect because knowing where to get the medication, who will administer it, and what positive effects to watch for are important aspects of medication management but do not directly assess the patient's understanding of potential adverse effects and safety measures. The focus should be on ensuring that the patient is well-informed about how to prevent and manage any negative outcomes related to the treatment.
Question 2 of 5
The nurse teaches the female patient receiving immune modulating drugs about the need to use barrier contraceptives. The patient says, I hate using barrier contraceptives. Why can't I just take oral contraceptives? What is the nurse's best response?
Correct Answer: A
Rationale: The correct answer is A: Effects of oral contraceptives may be altered by liver changes or changes in immune response. Rationale: 1. Immune modulating drugs can affect liver function, potentially altering the metabolism of oral contraceptives. 2. Liver changes can impact the effectiveness of oral contraceptives by either increasing or decreasing their levels in the body. 3. Changes in immune response can also interfere with the hormonal balance maintained by oral contraceptives, leading to decreased efficacy. 4. Barrier contraceptives are recommended to prevent unintended pregnancies due to the potential interactions between immune modulating drugs and oral contraceptives. Summary of other choices: B: Incorrect. Oral contraceptives do not increase the action of immune modulating drugs; they may interact with them due to changes in metabolism. C: Incorrect. Immune modulators can affect oral contraceptives through liver metabolism rather than hormonal impact. D: Incorrect. High-estrogen pills are not the only option if barrier contrace
Question 3 of 5
The nurse is caring for a patient diagnosed with rheumatoid arthritis (RA) who recently underwent a liver transplant. What immunosuppressant could this patient be prescribed that would treat both diagnoses?
Correct Answer: A
Rationale: Step 1: Anakinra is a recombinant, human interleukin-1 receptor antagonist that is used to treat rheumatoid arthritis by reducing inflammation. Step 2: Anakinra does not have significant liver toxicity, making it suitable for a patient who recently underwent a liver transplant. Step 3: Anakinra targets the immune system to reduce inflammation in RA, making it an appropriate immunosuppressant for the patient. Step 4: Adalimumab (Humira) and Sirolimus (Rapamune) are not typically used to treat RA or liver transplant patients. Step 5: Cyclosporine (Sandimmune) can be used for immunosuppression but has more potential for liver toxicity compared to Anakinra, making it less suitable for this patient.
Question 4 of 5
A recent laboratory results indicated an “undetectable†human immunodeficiency virus viral load. What is the nurse's best response?
Correct Answer: D
Rationale: The correct answer is D. The nurse should educate the patient about the continued need for medications and ongoing monitoring because an undetectable viral load does not mean the medication stopped working. The virus is suppressed but still present, so adherence to medications is crucial. Choice A is incorrect as an undetectable viral load is a positive outcome. Choice B is incorrect as rescheduling the visit is unnecessary. Choice C is incorrect as simply congratulating the patient does not address the importance of medication adherence and monitoring.
Question 5 of 5
All transplant drugs have the same advisory, to use caution when administering them with another immunosuppressant drug because of the increased risk for:
Correct Answer: D
Rationale: The correct answer is D: Infection. When transplant drugs are combined with other immunosuppressant drugs, the immune system is further weakened, increasing the risk of infections. This is because immunosuppressants reduce the body's ability to fight off pathogens. Nausea and vomiting (A), edema (B), and anemia (C) are not directly linked to the interaction between transplant drugs and other immunosuppressants. Infections are the primary concern due to the compromised immune response.